Zinc transporters, mechanisms of action and therapeutic utility: implications for type 2 diabetes mellitus
- PMID: 23304467
- PMCID: PMC3530793
- DOI: 10.1155/2012/173712
Zinc transporters, mechanisms of action and therapeutic utility: implications for type 2 diabetes mellitus
Abstract
Zinc is an essential trace element that plays a vital role in maintaining many biological processes and cellular homeostasis. Dysfunctional zinc signaling is associated with a number of chronic disease states including cancer, cardiovascular disease, Alzheimer's disease, and diabetes. Cellular homeostasis requires mechanisms that tightly control the uptake, storage, and distribution of zinc. This is achieved through the coordinated actions of zinc transporters and metallothioneins. Evidence on the role of these proteins in type 2 diabetes mellitus (T2DM) is now emerging. Zinc plays a key role in the synthesis, secretion and action of insulin in both physiological and pathophysiological states. Moreover, recent studies highlight zinc's dynamic role as a "cellular second messenger" in the control of insulin signaling and glucose homeostasis. This suggests that zinc plays an unidentified role as a novel second messenger that augments insulin activity. This previously unexplored concept would raise a whole new area of research into the pathophysiology of insulin resistance and introduce a new class of drug target with utility for diabetes pharmacotherapy.
Figures
References
-
- Charbonnel B, Cariou B. Pharmacological management of type 2 diabetes: the potential of incretin-based therapies. Diabetes, Obesity and Metabolism. 2011;13(2):99–117. - PubMed
-
- Wright EE, Stonehouse AH, Cuddihy RM. In support of an early polypharmacy approach to the treatment of type 2 diabetes. Diabetes, Obesity and Metabolism. 2010;12(11):929–940. - PubMed
-
- Jansen J, Karges W, Rink L. Zinc and diabetes—clinical links and molecular mechanisms. The Journal of Nutritional Biochemistry. 2009;20(6):399–417. - PubMed
-
- Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice. 2010;87(1):4–14. - PubMed
-
- Youngman S. Advanced Renal Care. Blackwell Publishing; 2008. Diabetes and renal failure; pp. 122–133.
LinkOut - more resources
Full Text Sources
Other Literature Sources
